In-Pharmatechnologist covered CURE’s newest patent filing and the potential of this new technology.

Cure Pharmaceutical has submitted a patent application for an oral film delivery technology it says can combine several active pharmaceutical ingredients without negative interaction. The patent application, titled ‘Pharmaceutical Composition with Ionically Crosslinked Polymer Encapsulation of Active Ingredient’ (US20170100327), covers the proprietary matrix, encapsulation technologies and the manufacturing process for the California, US headquartered company’s oral film delivery platform, CureFilm. The firm will target “companies that need to have a better delivery vehicle for their proprietary APIs,” with its platform in order to deliver medicines for orphan, geriatric and paediatric diseases, a spokesperson told inPharmaTechnologist.

Read the full article here